Rococlos Vet. injektionsvæske, emulsion

Authorised

Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Clostridium perfringens, type C, beta toxoid

Download as PDF

Product identification

Medicine name:

Rococlos Vet. injektionsvæske, emulsion

Active substance:

Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Clostridium perfringens, type C, beta toxoid
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Porcine rotavirus A, strain OSU 6, Inactivated
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated
Clostridium perfringens, type C, beta toxoid

Target species:

Route of administration:

Intramuscular use

Product details

Active substance and strength:

Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated

1.00

relative potency

/

1.00

Dose
Porcine rotavirus A, strain OSU 6, Inactivated

1.00

relative potency

/

1.00

Dose
Porcine rotavirus A, strain OSU 6, Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Clostridium perfringens, type C, beta toxoid

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Clostridium perfringens, type C, beta toxoid

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Clostridium perfringens, type C, beta toxoid

1.00

relative potency

/

1.00

Dose
Porcine rotavirus A, strain OSU 6, Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Porcine rotavirus A, strain OSU 6, Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated

1.00

relative potency

/

1.00

Dose
Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated

1.00

relative potency

/

1.00

Dose
Clostridium perfringens, type C, beta toxoid

1.00

relative potency

/

1.00

Dose

Pharmaceutical form:

Emulsion for injection

Withdrawal period by route of administration:

Intramuscular use
- Pig
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day
  - Meat
    
    0
    
    day

Legal status of supply:

Veterinary medicinal product subject to veterinary prescription

Authorisation status:

Valid

Authorised in:

Denmark

Available in:

Denmark

Package description:

Available only in Danish
Available only in Danish
Available only in Danish
Available only in Danish
Available only in Danish

Additional information

Entitlement type:

Marketing Authorisation

Legal basis of product authorisation:

Full application - known active substance (Article 8 of Regulation (EU) 2019/6)

Marketing authorisation holder:

Salfarm Danmark A/S

Marketing authorisation date:

19/12/2025

Manufacturing sites for batch release:

Bioveta a.s.

Responsible authority:

Danish Medicines Agency

Authorisation number:

72024

Date of authorisation status change:

19/12/2025

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.

Other languages (1)

Danish (, INJEKTIONSVÆSKE, EMULSION)

Published on: 24/06/2026

Download

Rococlos Vet. injektionsvæske, emulsion

Product identification

Product details

Additional information

Documents

Product information